Apellis Pharmaceuticals, Inc. (APLS)
25.86
+0.74
(+2.95%)
USD |
NASDAQ |
Jan 02, 16:00
25.85
-0.01
(-0.04%)
After-Hours: 20:00
Apellis Pharmaceuticals EPS Diluted (TTM): 0.297 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Biogen, Inc. | 10.97 |
| Amicus Therapeutics, Inc. | -0.0446 |
| Fortress Biotech, Inc. | -0.2677 |
| Ultragenyx Pharmaceutical, Inc. | -5.939 |
| Fulcrum Therapeutics, Inc. | -1.179 |